Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of GL0034

NCT07385547 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries Limited as lead sponsor.

NCT NCT07385547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07385547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of GL0034
Lead sponsor
Sun Pharmaceutical Industries Limited
Phase
Phase 1
Overall status
Recruiting
Start date
February 25, 2026
Completion date
September 27, 2026
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus